• Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

CGEN:US

8.4700 USD 0.0700 0.82%

As of 09:48:17 ET on 07/28/2014.

Snapshot for Compugen Ltd (CGEN)

Open: 8.5400 Day's Range: 8.4600 - 8.5400 Volume: 16,522
Previous Close: 8.5400 52wk Range: 5.2101 - 14.3200 1-Yr Rtn: +62.64%

Stock Chart for CGEN

No chart data available.
  • CGEN:US 8.4700
  • 1D
  • 1M
  • 1Y
8.5400
Interactive CGEN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for CGEN

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.3100
Est. EPS (USD) (12/2014) -0.2870
Est. PEG Ratio -
Market Cap (M USD) 412.54
Shares Outstanding (M) 48.31
30 Day Average Volume 167,713
Price/Book (mrq) 4.1033
Price/Sale (ttm) 63.4551
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/07/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for CGEN

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for CGEN

Compugen Ltd. develops solutions in the field of computational genomics. The Company provides its gene discovery tools to pharmaceutical, biotechnology, and other life sciences through its Web site, labOnWeb.com. Compugen is also seeking to commercialize the genes and proteins it discovers.

Anat Cohen-DayagPresident/CEOAvihai ShenInterim CFO
John J HunterVP:Antibody Research & Dev
More Company Profile & Key Executives for CGEN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil